180211

Organization name

Reagena Oy

SRN

FI-MF-000002804

Manufacturer status

Active

10 warnings recorded — scroll inside the panel to see all entries.

• CW010

  EUDAMED did not publish a description for this code.
• CW075

  EUDAMED did not publish a description for this code.
• CW079

  EUDAMED did not publish a description for this code.
• CW087

  EUDAMED did not publish a description for this code.
• CW057

  EUDAMED did not publish a description for this code.
• CW099

  EUDAMED did not publish a description for this code.
• CW139

  EUDAMED did not publish a description for this code.
• CW148

  EUDAMED did not publish a description for this code.
• CW167

  EUDAMED did not publish a description for this code.
• CW291

  EUDAMED did not publish a description for this code.

Primary placement in Finland; available across 32 countries total.

Trade name

not provided

UDI-DI code

06430074451714

Basic UDI-DI

6430074451002118W

Reference / catalog number

180211

Issuing entity

GS1

Risk category

IVDR Class A

Applicable legislation

IVDR [Regulation (EU) 2017/746 on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

May-Grünwald solution is intended to be used together with Giemsa solution for May-Grünwald-Giemsa (MGG) staining.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• W0103010302ROMANOWSKY STAINS

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

Certificate health across this manufacturer's portfolio.